MindRank AI is a developer of proprietary end-to-end AI-driven drug-discovery platform (Molecule Proâ¢). Founded by Zhangming Niu in 2020, MindRank AI is backed by Sherpa Venture Capital, Huagai Capital, and Green Pine Capital Partners and is headquartered in Shanghai.